General MedicationsINHALATIONStandard
CAYSTON
AZTREONAM
Standard Dose
75MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview CAYSTON is listed in Drugs@FDA under application 050814 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient AZTREONAM Form and strength FOR SOLUTION;INHALATION - 75MG/VIAL Sponsor GILEAD Submission history Latest submission status date: 2019-11-20 00:00:00.
Structured Monograph
Clinical summary
Approval overview CAYSTON is listed in Drugs@FDA under application 050814 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient AZTREONAM Form and strength FOR SOLUTION;INHALATION - 75MG/VIAL Sponsor GILEAD Submission history Latest submission status date: 2019-11-20 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.